Blood Glucose Device Market Drivers, Opportunities, Trends, and Forecasts by 2031

Coverage: Blood Glucose Device Market covers analysis By Type ( Self-Monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring Devices ); Technique ( Invasive, Non-Invasive ); Distribution Channel ( Hospital Pharmacy, Retail Pharmacy, Online Sales ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00019608
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

The Blood Glucose Device Market is expected to register a CAGR of 8.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.

The report is segmented by Type ( Self-Monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring Devices ). The report is segmented by Technique ( Invasive, Non-Invasive ). The report is segmented by Distribution Channel ( Hospital Pharmacy, Retail Pharmacy, Online Sales ). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Blood Glucose Device Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Blood Glucose Device Market Segmentation

Type

  • Self-Monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring Devices

Technique

  • Invasive
  • Non-Invasive

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Geography

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Geography

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Blood Glucose Device Market: Strategic Insights

blood-glucose-device-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Blood Glucose Device Market Growth Drivers

  • Rising Prevalence of Diabetes: Causes of diabetes, particularly Type 2 diabetes are being referred to as epidemics in this modern age. As reported by the International Diabetes Federation (IDF), the diabetes population all over the world is more than five hundred million, in which figure an upward trend is observed in the following years. The number of diabetes cases increases with the aging of the population and due to lower dietary habits hence the need for blood glucose monitoring devices increases. The rise in diabetes prevalence is also one of the factors contributing to the growth of the market, following the fact that both patients and health care systems are in need of better and more accessible methods of controlling blood sugar levels.
  • Technological Advancements in Blood Glucose Monitoring: The blood glucose monitoring device market is witnessing several advancements that include smart glucose meters, wearable devices with real-time glucose updates, and continuous glucose monitors The Comparative advantages of Glucose monitoring devices over conventional glucometers are as follows: CGM as compared to external monitoring devices are fixed on the body and monitor the glucose levels of the user on a 24hour basis all through the day. This helps in giving better control and management of diabetes. Better yet, this is complemented by mobile applications and cloud services that permit patients and their clinicians to view trends and adjust treatment in real-time. These improvements not only enhance accuracy but also improve the customer experience thereby increasing the purchases of the devices.
  • Shift Towards Personalized Healthcare: There is a fashion for personal or precision medicine, and also in the case of diabetes, management has become more person-focused. Glucometer devices today come with additional functionalities such as data analytics which helps patient recognize their specific glucose tendencies in the course of his or her daily activities. Given these factors, there is a positive trend in the creation of devices that do not merely assess glucose but which look at lifestyle changes as well.

Blood Glucose Device Market Future Trends

  • Linkage with Smartphone Health Apps: The usage of blood glucose monitoring devices linked with mobile phones and mobile health applications is on a rise. In fact, several glucose meters are now being designed with Bluetooth connectivity features, which allows the users to connect the mobile application and upload their data. This helps in analyzing the trends over intervals, sending alerts for blood test schedules, and sending reports to their physicians. This changing landscape is likely to enhance and encourage more patient engagement as due to the increased adoption of smartphones and digital health tools, the trend will always be on the upsurge.
  • Wearable Devices and Non-Invasive Monitoring: In fact, the blood glucose device market is benefitting from the wearable application in an unprecedented way. Non-invasive blood glucose monitors which do not involve pricking the skin, are also a welcome development that seeks to alleviate the suffering of diabetes patients in managing their conditions. Gadgets like the Dexcom G6 or Abbott’s FreeStyle Libre are external Continuous Glucose Monitors (CGMs) that provide realtime glucose readings 24 hours. In addition to Continuous Glucose Monitors (CGMs), there is ongoing research on devices like transdermal patches and sensors aimed at providing non-invasive options thereby enhancing possibilities for users.
  • Concentrate on AI plus Data Analysis: One more significant tendency is the adoption of artificial intelligence (AI) and machine learning technologies to aid in controlling blood sugar levels especially in diabetics This Actually she introduced A1c levels and fixed A1c diabetes calculators but also affected how diabetes mellitus is managed Improving algorithms have been developed that allow more accurate predictions on glucose surges and even suggestions of food intake or exercises or drugs in administration when the bounty demands it. Arti?cial intelligence (AI) uses extensive data obtained from glucose meters and health devices to design the most effective and custom-fit treatment regimens for individuals. This innovative technology has the capability of reversing diabetes management from reactive to proactive thereby leading to better patient results.

Blood Glucose Device Market Opportunities

  • Disrupting the Status Quo of Glucometers: Non-invasive glucose monitoring has a thriving market potential and this is likely to attract device manufacturing companies. From wearable sensors to sweat based monitors and optical sensors, non invasive devices are bound to change the management of diabetes in a less painful and more convenient way than simply fingerstick tests. There is still an appetite for new ways of innovating, especially for companies who want to invest in the non-invasive research and development technologies.
  • Integrating Blood Glucose Monitoring Devices with Digital Health Application: As the devices to measure blood glucose increase in numbers, so will the possibilities of their integration with the help of other devices and applications committed to similar goals. Without knowing, these players are adding to the combination of clinical solutions focused exclusively on diabetes - devices, medications, services, thence the need for glucose meters. Therefore, such collaborations can immensely enhance the value of the users experience by making it possible to monitor, track and keep in control over the patients health progress, offer reminders and recommendations specific to a patient, thus increasing adherence and health results.
  • Personalized Solutions for Diabetes Management: A shift towards personalization in diabetes care opens an avenue that device manufacturers can take advantage of by making devices that allow integration of lifestyle variables with glucose levels. These are devices that monitor glucose and other health parameters such as physical activity, nutrition, and sleep. In practice, such devices will facilitate the development of better products which will seek to enable patients to manage their conditions, thus improving disease management and greater treatment satisfaction.

Blood Glucose Device Market Regional Insights

The regional trends and factors influencing the Blood Glucose Device Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Blood Glucose Device Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

blood-glucose-device-market-global-geography
  • Get the Regional Specific Data for Blood Glucose Device Market

Blood Glucose Device Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) 8.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Self-Monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring Devices
By Technique
  • Invasive
  • Non-Invasive
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Braun Melsungen AG
  • Medtronic
  • DiaMonTech GmbH
  • Terumo Medical Corporation
  • Lifespan Inc.
  • Hoffmann-La Roche Ltd.
  • Sanofi
  • Abbott
  • Ascensia Diabetes Care Holdings AG.

  • Blood Glucose Device Market Players Density: Understanding Its Impact on Business Dynamics

    The Blood Glucose Device Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Blood Glucose Device Market are:

    1. Braun Melsungen AG
    2. Medtronic
    3. DiaMonTech GmbH
    4. Terumo Medical Corporation
    5. Lifespan Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    blood-glucose-device-market-speedometer

    • Get the Blood Glucose Device Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Glucose Device Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Blood Glucose Device Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Which segment accounts for highest revenue by type in 2023?

    Self-Monitoring Blood Glucose Devices Market segment, by type, dominated the market in 2023.

    Which are some of the players operating in the Blood Glucose Device Market market?

    Players operating in the market are Braun Melsungen AG, Medtronic, DiaMonTech GmbH, Terumo Medical Corporation, Lifespan Inc., Hoffmann-La Roche Ltd., Sanofi, Abbott, Ascensia Diabetes Care Holdings AG, Dexcom, Inc.

    What are the factor that act as a opportunity for market growth?

    Linkage with Smartphone Health Apps act as a opportunity for growth of the market in forecast period.

    Which region dominated the Blood Glucose Device Market market in 2023?

    North America region dominated the Blood Glucose Device Market market in 2023.

    What is the expected CAGR of the Blood Glucose Device Market?

    The Blood Glucose Device Market is estimated to witness a CAGR of 8.3% from 2023 to 2031

    What are the driving factors impacting the Blood Glucose Device Market market?

    The major factors driving the Blood Glucose Device Market market are:

    1. Rising Prevalence of Diabetes

    2. Technological Advancements in Blood Glucose Monitoring

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Braun Melsungen AG
    2. Medtronic
    3. DiaMonTech GmbH
    4. Terumo Medical Corporation
    5. Lifespan Inc.
    6. Hoffmann-La Roche Ltd.
    7. Sanofi
    8. Abbott
    9. Ascensia Diabetes Care Holdings AG.
    10. Dexcom, Inc

    Buy Now